# Diceros Therapeutics, Inc. — Form D/A

Diceros Therapeutics, Inc. of NEWTON, MA, a company, filed a Form D amendment with the SEC on 2024-08-05. The offering totals $18.1M, of which $12.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-05
- Form: D/A
- Accession: 0001948469-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.1M
- Amount sold: $12.6M
- Remaining: $5.5M
- Investors: 13
- Date of first sale: 2022-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460347

## Issuer

- Name: Diceros Therapeutics, Inc.
- CIK: 0001948469
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 275 GROVE STREET, 2-400, NEWTON, MA, 02466
- Phone: 617-663-5784

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jonathan R Fleming | Director | Newton, MA |
| Wyatt R Gotbetter | Director | Newton, MA |
| Stephen R Seiler | Director | Newton, MA |
| Ids R van der Weij | Director | Newton, MA |
| Stephen R Seiler | Executive Officer | Newton, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-09-30](https://search.stillhousedata.com/formd/0001948469-22-000001) | D | $16.7M | $6.7M |

## More

- [CIK 1948469 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1948469&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001948469-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.